Cellect(QNRX) - 2020 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission File No.: 001-37846 CELLECT BIOTECHNOLOGY LTD. (Exact name of registrant as specified in its charter) Translation of registrant's name into English: Not applicable 23 Hata'as Street Kfar Saba, Israel 44425 (+972) (9) 974 1444 State of Israel (Jurisdiction of incorporation or organization) (A ...